Isbn: 9786200507099 - oxaprozin loaded solid lipid nanoparticles for management of pain: novel development of oxaprozin loaded solid lipid nanoparticles for effective management of pain (3 Ergebnisse)

ISBN: 
Mit der Detailsuche verfeinern

Optimieren Sie Ihre Suche

  • Bücher (3)

bis

Benutzerdefinierte Preisspanne (EUR)

bis

  • Sprache: Englisch

    Verlag: LAP LAMBERT Academic Publishing, 2020

    6200507090 / 9786200507099

    • Softcover

    Anbieter: preigu, Osnabrück, Deutschlandpreigu

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 36,35

    EUR 70,00 Versand 
    Versand von Deutschland nach USA

    Anzahl: 5 verfügbar

    Taschenbuch. Zustand: Neu. Oxaprozin loaded solid lipid nanoparticles for management of pain | Novel Development of Oxaprozin loaded Solid Lipid Nanoparticles for effective management of pain | Vinod K. Dhote (u. a.) | Taschenbuch | 76 S. | Englisch | 2020 | LAP LAMBERT Academic Publishing | EAN 9786200507099 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.…

  • Sprache: Englisch

    Verlag: LAP LAMBERT Academic Publishing, 2020

    6200507090 / 9786200507099

    • Softcover

    Anbieter: Buchpark, Trebbin, DeutschlandBuchpark

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Gebraucht - Sehr gut

    EUR 33,59

    EUR 105,00 Versand 
    Versand von Deutschland nach USA

    Anzahl: 1 verfügbar

    Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Solid lipid nanoparticles (SLN) introduced in 1991 represent an alternative carrier system to tradition colloidal carriers such as emulsions, liposomes and polymeric micro and nanoparticles. Nanoparticles made from solid lipids are attracting major attention as novel colloidal drug carrier for intravenous applications as they have been proposed as an alternative particulate carrier system. SLN are sub-micron colloidal carriers ranging from 50 to 1000 nm, which are composed of physiological lipid, dispersed in water or in aqueous surfactant solution. SLN offer unique properties such as small size, large surface area, high drug loading and the interaction of phases at the interface and are attractive for their potential to improve performance of pharmaceuticals. The Solid lipid nanoparticles were successfully developed for systemic delivery of Oxaprozin. SLN dispersions were prepared by solvent injection method. Physicochemical characterization including particle size, particle size distribution, Zeta potential, scanning electron microscopy and in-vitro release profile were carried out. In-vitro drug release pattern of optimized formulation of SLN showed fast and control release.…

  • Sprache: Englisch

    Verlag: LAP LAMBERT Academic Publishing, 2020

    6200507090 / 9786200507099

    • Softcover

    Anbieter: Buchpark, Trebbin, DeutschlandBuchpark

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Gebraucht

    EUR 34,60

    EUR 105,00 Versand 
    Versand von Deutschland nach USA

    Anzahl: 1 verfügbar

    Zustand: Hervorragend. Zustand: Hervorragend | Sprache: Englisch | Produktart: Bücher | Solid lipid nanoparticles (SLN) introduced in 1991 represent an alternative carrier system to tradition colloidal carriers such as emulsions, liposomes and polymeric micro and nanoparticles. Nanoparticles made from solid lipids are attracting major attention as novel colloidal drug carrier for intravenous applications as they have been proposed as an alternative particulate carrier system. SLN are sub-micron colloidal carriers ranging from 50 to 1000 nm, which are composed of physiological lipid, dispersed in water or in aqueous surfactant solution. SLN offer unique properties such as small size, large surface area, high drug loading and the interaction of phases at the interface and are attractive for their potential to improve performance of pharmaceuticals. The Solid lipid nanoparticles were successfully developed for systemic delivery of Oxaprozin. SLN dispersions were prepared by solvent injection method. Physicochemical characterization including particle size, particle size distribution, Zeta potential, scanning electron microscopy and in-vitro release profile were carried out. In-vitro drug release pattern of optimized formulation of SLN showed fast and control release.…